Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.

[1]  S. Finklestein,et al.  Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue. , 1986, Life sciences.

[2]  J. Commissiong.  Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity. , 1985, Biochemical pharmacology.

[3]  G. Breese,et al.  Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. , 1984, The Journal of pharmacology and experimental therapeutics.

[4]  L. Manzino,et al.  Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. , 1984, European journal of pharmacology.

[5]  A. M. Snyder,et al.  Effect of dopamine-depleting brain lesions on suckling and weaning in rats. , 1984, Behavioral neuroscience.

[6]  A. M. Snyder,et al.  Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats , 1984, Brain Research.

[7]  B. Shaywitz,et al.  Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat , 1983, Pharmacology Biochemistry and Behavior.

[8]  A. Stoll,et al.  Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat , 1983, Brain Research.

[9]  O. Lindvall,et al.  Prefrontal cortex: dense dopaminergic input in the newborn rat. , 1982, Brain research.

[10]  G. Sperk.  Simultaneous Determination of Serotonin, 5‐Hydroxyindoleacetic Acid, 3,4‐Dihydroxyphenylacetic Acid and Homovanillic Acid by High Performance Liquid Chromatography with Electrochemical Detection , 1982, Journal of neurochemistry.

[11]  N. A. Buchwald,et al.  Development of spontaneous neuronal activity in the caudate nucleus, globus pallidus-entopeduncular nucleus, and substantia nigra of the cat. , 1982, Brain research.

[12]  T. Heffner,et al.  Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion , 1981, Brain Research.

[13]  Martin H. Teicher,et al.  Effects of bromocriptine in developing rat pups after 6-hydroxydopamine , 1981, Pharmacology Biochemistry and Behavior.

[14]  R. Roth,et al.  Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis. , 1981, Molecular pharmacology.

[15]  Martin H. Teicher,et al.  Differential effects of maternal and sibling presence of hyperactivity of 6-hydroxydopamine-treated developing rats. , 1981, Journal of comparative and physiological psychology.

[16]  J. McLean,et al.  Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior , 1979, Pharmacology Biochemistry and Behavior.

[17]  P. Kissinger,et al.  DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHY , 1978, Journal of neurochemistry.

[18]  B. Shaywitz,et al.  Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine , 1976, Nature.

[19]  B. Shaywitz,et al.  Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. , 1976, Science.

[20]  D. Jacobowitz,et al.  Pharmacological actions of 6-hydroxydopamine. , 1974, Pharmacological reviews.

[21]  A. Oke,et al.  Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels. , 1974, European journal of pharmacology.

[22]  B. Cooper,et al.  Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine. , 1973, The Journal of pharmacology and experimental therapeutics.

[23]  K. Taylor,et al.  Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats. , 1972, Nature: New biology.

[24]  C. Sachs,et al.  Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals. , 1972, Research communications in chemical pathology and pharmacology.

[25]  R. Laverty,et al.  Long‐lasting peripheral and central effects of 6‐hydroxydopamine in rats , 1972, British journal of pharmacology.

[26]  G. Breese,et al.  Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6‐hydroxydopamine , 1972, British journal of pharmacology.

[27]  R. Mclean,et al.  A common error in assessing the significance of percentage change in neuropharmacology , 1971, The Journal of pharmacy and pharmacology.

[28]  F. Bloom,et al.  Lesions of Central Norepinephrine Terminals with 6-OH-Dopamine: Biochemistry and Fine Structure , 1969, Science.

[29]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.

[30]  Joachim F. R. König,et al.  The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem , 1986 .